U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07202871) titled 'A Study of How the Body Absorbs LY3537031' on Sept. 24.

Brief Summary: The main purpose of this study is to find out how much LY3537031 gets into the blood stream and how long it takes the body to get rid of it when it is injected just under the skin in different parts of the body, and when it is injected into a vein, in healthy participants. This study will also look at the safety and tolerability of LY3537031.

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: LY3537031

Administered SC

DRUG: LY3537031

Administered IV

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eli Lilly and...